189 related articles for article (PubMed ID: 38474285)
1. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy.
Wang G; Xie Z; Su J; Chen M; Du Y; Gao Q; Zhang G; Zhang H; Chen X; Liu H; Han L; Ye Y
Cancer Res; 2022 Oct; 82(19):3474-3485. PubMed ID: 35930727
[TBL] [Abstract][Full Text] [Related]
3. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
[TBL] [Abstract][Full Text] [Related]
4. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
Kim N; Chung W; Eum HH; Lee HO; Park WY
PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression.
Lianoglou S; Garg V; Yang JL; Leslie CS; Mayr C
Genes Dev; 2013 Nov; 27(21):2380-96. PubMed ID: 24145798
[TBL] [Abstract][Full Text] [Related]
6. The landscape of alternative polyadenylation in single cells of the developing mouse embryo.
Agarwal V; Lopez-Darwin S; Kelley DR; Shendure J
Nat Commun; 2021 Aug; 12(1):5101. PubMed ID: 34429411
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo.
Gabel AM; Belleville AE; Thomas JD; McKellar SA; Nicholas TR; Banjo T; Crosse EI; Bradley RK
Nat Commun; 2024 Feb; 15(1):959. PubMed ID: 38302465
[TBL] [Abstract][Full Text] [Related]
8. Quantifying alternative polyadenylation in RNAseq data with LABRAT.
Gillen AE; Goering R; Taliaferro JM
Methods Enzymol; 2021; 655():245-263. PubMed ID: 34183124
[TBL] [Abstract][Full Text] [Related]
9. APA-Scan: detection and visualization of 3'-UTR alternative polyadenylation with RNA-seq and 3'-end-seq data.
Fahmi NA; Ahmed KT; Chang JW; Nassereddeen H; Fan D; Yong J; Zhang W
BMC Bioinformatics; 2022 Sep; 23(Suppl 3):396. PubMed ID: 36171568
[TBL] [Abstract][Full Text] [Related]
10. Diverse cell-specific patterns of alternative polyadenylation in Drosophila.
Lee S; Chen YC; ; Gillen AE; Taliaferro JM; Deplancke B; Li H; Lai EC
Nat Commun; 2022 Sep; 13(1):5372. PubMed ID: 36100597
[TBL] [Abstract][Full Text] [Related]
11. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma.
Zhong W; Wu Y; Zhu M; Zhong H; Huang C; Lin Y; Huang J
Mol Ther Nucleic Acids; 2022 Mar; 27():927-946. PubMed ID: 35211354
[TBL] [Abstract][Full Text] [Related]
13. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.
Liu D; Yang X; Wu X
Front Immunol; 2021; 12():663495. PubMed ID: 34025664
[TBL] [Abstract][Full Text] [Related]
14. Distinct, opposing functions for CFIm59 and CFIm68 in mRNA alternative polyadenylation of Pten and in the PI3K/Akt signalling cascade.
Tseng HW; Mota-Sydor A; Leventis R; Jovanovic P; Topisirovic I; Duchaine TF
Nucleic Acids Res; 2022 Sep; 50(16):9397-9412. PubMed ID: 35993810
[TBL] [Abstract][Full Text] [Related]
15. TREND-DB-a transcriptome-wide atlas of the dynamic landscape of alternative polyadenylation.
Marini F; Scherzinger D; Danckwardt S
Nucleic Acids Res; 2021 Jan; 49(D1):D243-D253. PubMed ID: 32976578
[TBL] [Abstract][Full Text] [Related]
16. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
17. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
Lan YL; Zhang J
Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
[No Abstract] [Full Text] [Related]
19. Alternative polyadenylation in the nervous system: to what lengths will 3' UTR extensions take us?
Miura P; Sanfilippo P; Shenker S; Lai EC
Bioessays; 2014 Aug; 36(8):766-77. PubMed ID: 24903459
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
Xiang Y; Ye Y; Lou Y; Yang Y; Cai C; Zhang Z; Mills T; Chen NY; Kim Y; Muge Ozguc F; Diao L; Karmouty-Quintana H; Xia Y; Kellems RE; Chen Z; Blackburn MR; Yoo SH; Shyu AB; Mills GB; Han L
J Natl Cancer Inst; 2018 Apr; 110(4):379-389. PubMed ID: 29106591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
